Galecto (GLTO) Competitors $2.98 -0.09 (-2.78%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$2.99 +0.02 (+0.50%) As of 05/21/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLTO vs. FLGC, BCDA, GOVX, EQ, EDSA, LPTX, MEIP, PRPH, GELS, and MEShould you be buying Galecto stock or one of its competitors? The main competitors of Galecto include Flora Growth (FLGC), BioCardia (BCDA), GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), Leap Therapeutics (LPTX), MEI Pharma (MEIP), ProPhase Labs (PRPH), Gelteq (GELS), and 23andMe (ME). These companies are all part of the "pharmaceutical products" industry. Galecto vs. Flora Growth BioCardia GeoVax Labs Equillium Edesa Biotech Leap Therapeutics MEI Pharma ProPhase Labs Gelteq 23andMe Galecto (NASDAQ:GLTO) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has higher valuation & earnings, GLTO or FLGC? Galecto has higher earnings, but lower revenue than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalectoN/AN/A-$38.35M-$15.53-0.19Flora Growth$53.26M0.27-$57.04M-$0.98-0.64 Is GLTO or FLGC more profitable? Galecto has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. Galecto's return on equity of -76.96% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets GalectoN/A -76.96% -66.59% Flora Growth -30.99%-268.17%-57.51% Do insiders and institutionals hold more shares of GLTO or FLGC? 14.2% of Galecto shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 10.8% of Galecto shares are owned by company insiders. Comparatively, 12.6% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend GLTO or FLGC? Galecto presently has a consensus target price of $10.00, indicating a potential upside of 236.13%. Flora Growth has a consensus target price of $4.00, indicating a potential upside of 534.92%. Given Flora Growth's higher possible upside, analysts clearly believe Flora Growth is more favorable than Galecto.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galecto 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community favor GLTO or FLGC? Galecto received 17 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 60.38% of users gave Galecto an outperform vote while only 60.00% of users gave Flora Growth an outperform vote. CompanyUnderperformOutperformGalectoOutperform Votes3260.38% Underperform Votes2139.62% Flora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Does the media prefer GLTO or FLGC? In the previous week, Flora Growth had 4 more articles in the media than Galecto. MarketBeat recorded 4 mentions for Flora Growth and 0 mentions for Galecto. Galecto's average media sentiment score of 0.00 beat Flora Growth's score of -0.59 indicating that Galecto is being referred to more favorably in the media. Company Overall Sentiment Galecto Neutral Flora Growth Negative Which has more risk & volatility, GLTO or FLGC? Galecto has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. SummaryGalecto and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks. Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLTO vs. The Competition Export to ExcelMetricGalectoPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.93M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-0.168.9226.8419.71Price / SalesN/A253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.106.466.794.50Net Income-$38.35M$143.98M$3.23B$248.18M7 Day Performance2.23%2.03%1.53%0.20%1 Month Performance11.01%4.11%10.06%12.37%1 Year Performance-80.96%-2.87%16.72%7.04% Galecto Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLTOGalecto1.649 of 5 stars$2.98-2.8%$10.00+236.1%-80.9%$3.93MN/A-0.1640FLGCFlora Growth2.4924 of 5 stars$0.75+10.5%$5.00+566.7%-47.5%$14.58M$59.51M-0.57280Gap DownBCDABioCardia2.5542 of 5 stars$2.84-0.4%$25.00+780.3%-69.1%$14.47M$58,000.00-0.6840GOVXGeoVax Labs2.158 of 5 stars$0.93-0.3%$11.10+1,099.9%-39.1%$14.06M$5.59M-0.2510EQEquillium2.6304 of 5 stars$0.39-0.1%$3.00+669.2%-74.5%$13.93M$41.10M-2.7940EDSAEdesa Biotech2.8404 of 5 stars$1.98-3.4%$21.00+960.6%-55.7%$13.91MN/A-1.0620Gap DownLPTXLeap Therapeutics2.4352 of 5 stars$0.38+12.0%$4.92+1,210.8%-85.6%$13.88MN/A-0.1940MEIPMEI Pharma2.2004 of 5 stars$2.08+1.3%N/A-31.1%$13.83M$65.30M-0.36100PRPHProPhase Labs1.8868 of 5 stars$0.33+7.9%N/A-94.4%$13.69M$6.77M-0.26130News CoverageEarnings ReportGap UpGELSGelteqN/A$1.44+5.1%N/AN/A$13.59MN/A0.00N/AGap UpME23andMeN/A$0.50-35.3%N/A-95.3%$13.36M$208.78M-0.03770Gap DownHigh Trading Volume Related Companies and Tools Related Companies Flora Growth Competitors BioCardia Competitors GeoVax Labs Competitors Equillium Competitors Edesa Biotech Competitors Leap Therapeutics Competitors MEI Pharma Competitors ProPhase Labs Competitors Gelteq Competitors 23andMe Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GLTO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.